CNTX
CNTX
NASDAQ · Pharmaceuticals

Context Therapeutics Inc

$0.20
+0.00 (+0.70%)
Analyst Consensus
Strong Buy
16
Analysts
High
Coverage
Buy 15 94%
Hold 1 6%
Sell 0 0%
Price Target
Analyst Price Target +11,640.2% upside
Low Target $16.27
Average Target $23.68
High Target $31.54
Current Price $0.20
Current
$0.20
Target
$23.68
$16.27 $23.68 avg $31.54
Scenario Analysis
Bear Case
$16.27
7,966.4%
Low target
Base Case
$23.68
+11,640.2%
Avg target
Bull Case
$31.54
+15,537.1%
High target
Risk/Reward
2.0x
Balanced
Price in Context
52-Week High
$3.62
-94.4% from high
52-Week Low
$0.19
+8.3% from low
Target vs 52W High
$23.68
+554.1% vs high
Next Earnings Report
Nov 11, 2026
Today
EPS Est: $-0.11
Earnings in today. Analyst targets may shift significantly after the report.
Peer Consensus — Pharmaceuticals
Stock Consensus Analysts Buy % Target Upside
LLY
Eli Lilly and Co.
Strong Buy 37 86% $1,330.33 -6.5%
RDY
Dr. Reddy's Laboratories
Sell 42 45% — +0.0%
JNJ
Johnson & Johnson
Buy 30 70% $299.55 +6.2%
MRK
Merck & Co. Inc.
Buy 35 71% $159.27 +8.5%
PFE
Pfizer Inc.
Hold 34 38% $33.90 +15.9%
BMY
Bristol-Myers Squibb Co
Hold 34 41% $174.50 +180.5%
RPRX
Royalty Pharma Plc- Cl A
Strong Buy 14 93% $36.26 -47.3%
ZTS
Zoetis Inc
Hold 22 41% $209.87 +156.1%